COMMUNIQUÉS West-GlobeNewswire

-
Ultragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children
26/03/2019 -
Scilex Holding, a Subsidiary of Sorrento Therapeutics, Announces Phase 2 Trial Results for its Leading SP-102 Program
26/03/2019 -
Agritek Holdings, Inc. Announces Proposed Purchase Agreement for Licensed Cannabis Cultivation and Manufacturing Facility in San Juan, Puerto Rico
26/03/2019 -
Protech Home Medical Announces Redemption of 7.5% Non-Convertible Unsecured Subordinated Debentures
26/03/2019 -
Vectura Group plc 2018 Preliminary Results
26/03/2019 -
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical Officer
26/03/2019 -
Oxford Biomedica notes the Japanese approval of Kymriah® (tisagenlecleucel), the first CAR-T cell therapy authorised in Asia
26/03/2019 -
Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility
26/03/2019 -
MediWound Files Annual Report on Form 20-F for the Year Ended December 31, 2018
26/03/2019 -
Notification from Oasmia Pharmaceutical AB
26/03/2019 -
Matinas BioPharma to Announce Full-Year 2018 Operational and Financial Results on April 2, 2019
26/03/2019 -
Blissco Signs Agreement to Supply New Brunswick with Premium Cannabis
26/03/2019 -
Predictive Technology Group Completes Acquisition of Taueret Laboratories
26/03/2019 -
iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit
26/03/2019 -
Kezar Life Sciences Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
26/03/2019 -
Neuronetics to Present at the 18th Annual Needham & Company Healthcare Conference
26/03/2019 -
Aura Announces Appointment of Alain Dobkin to its Board of Directors
26/03/2019 -
D.A. Wallach Joins BioSig Technologies Advisory Board
26/03/2019 -
MediPharm Labs Expands Legal Team Adding Cannabis Expertise and Announces Participation at Upcoming Conferences
26/03/2019
Pages